Dr. Jacob D. Soumerai, MD
Claim this profileMassachusetts General Hospital
Studies Chronic Lymphocytic Leukemia
Studies Lymphoma
8 reported clinical trials
14 drugs studied
Area of expertise
1Chronic Lymphocytic Leukemia
CD5 positive
CD19 positive
2Lymphoma
CD5 positive
CD19 positive
Affiliated Hospitals
Clinical Trials Jacob D. Soumerai, MD is currently running
JCAR017
for Chronic Leukemia or Lymphoma
This trial tests JCAR017, a therapy using modified immune cells, in adults with hard-to-treat CLL or SLL. It aims to see if these enhanced immune cells can better fight the cancer.
Recruiting1 award Phase 1 & 2
Venetoclax + Obinutuzumab +/- Acalabrutinib
for Chronic Lymphocytic Leukemia
This research study is studying a combination of drugs as a possible treatment for chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). The names of the study drugs involved in this study are: * obinutuzumab * venetoclax * acalabrutinib
Recruiting3 awards Phase 218 criteria
More about Jacob D. Soumerai, MD
Clinical Trial Related8 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Jacob D. Soumerai, MD has experience with
- Venetoclax
- Acalabrutinib
- Umbralisib
- Belantamab Mafodotin
- Obinutuzumab
- Ublituximab
Breakdown of trials Jacob D. Soumerai, MD has run
Chronic Lymphocytic Leukemia
Lymphoma
Leukemia
Follicular Lymphoma
Plasmablastic Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jacob D. Soumerai, MD specialize in?
Jacob D. Soumerai, MD focuses on Chronic Lymphocytic Leukemia and Lymphoma. In particular, much of their work with Chronic Lymphocytic Leukemia has involved CD5 positive patients, or patients who are CD19 positive.
Is Jacob D. Soumerai, MD currently recruiting for clinical trials?
Yes, Jacob D. Soumerai, MD is currently recruiting for 2 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Jacob D. Soumerai, MD has studied deeply?
Yes, Jacob D. Soumerai, MD has studied treatments such as Venetoclax, Acalabrutinib, Umbralisib.
What is the best way to schedule an appointment with Jacob D. Soumerai, MD?
Apply for one of the trials that Jacob D. Soumerai, MD is conducting.
What is the office address of Jacob D. Soumerai, MD?
The office of Jacob D. Soumerai, MD is located at: Massachusetts General Hospital, Boston, Massachusetts 02114 United States. This is the address for their practice at the Massachusetts General Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.